USP2 and neoplasm: Indeed, synergistic effects induced by the combination of a small-molecule USP2 inhibitor and anti-PD1 monoclonal antibody were also readily reproduced in the RM-1 tumor-bearing C57BL/6 mice without any obvious toxicity (Supplementary Fig. 12a–e).